Fig. 6From: Prioritization and functional assessment of noncoding variants associated with complex diseasesPerformance evaluation on cancer-related noncoding risk variants. a Common recurrent noncoding variants versus common non-recurrent noncoding variants. b Prioritizing recurrent variants from non-recurrent variants using PAFA with or without population-level features across ten cancer-related variant sets from ICGC. c Alteration of PAFA scores after removing population-level features in BTCA-JP and BOCA-FR. d Rare noncoding variants versus adjacent common noncoding variants extracted from 1000 Genomes. e Rare recurrent noncoding variants versus rare non-recurrent noncoding variantsBack to article page